<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2008-02-05" modified="2020-10-07" version="127">
<accession>Q53ET0</accession>
<accession>Q6UUV8</accession>
<accession>Q7Z3X7</accession>
<accession>Q8N332</accession>
<name>CRTC2_HUMAN</name>
<protein>
<recommendedName>
<fullName>CREB-regulated transcription coactivator 2</fullName>
</recommendedName>
<alternativeName>
<fullName>Transducer of regulated cAMP response element-binding protein 2</fullName>
<shortName>TORC-2</shortName>
<shortName>Transducer of CREB protein 2</shortName>
</alternativeName>
</protein>
<gene>
<name type="primary">CRTC2</name>
<name type="synonym">TORC2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2003" name="Proc. Natl. Acad. Sci. U.S.A." volume="100" first="12147" last="12152">
<title>Identification of a family of cAMP response element-binding protein coactivators by genome-scale functional analysis in mammalian cells.</title>
<authorList>
<person name="Iourgenko V."/>
<person name="Zhang W."/>
<person name="Mickanin C."/>
<person name="Daly I."/>
<person name="Jiang C."/>
<person name="Hexham J.M."/>
<person name="Orth A.P."/>
<person name="Miraglia L."/>
<person name="Meltzer J."/>
<person name="Garza D."/>
<person name="Chirn G.-W."/>
<person name="McWhinnie E."/>
<person name="Cohen D."/>
<person name="Skelton J."/>
<person name="Terry R."/>
<person name="Yu Y."/>
<person name="Bodian D."/>
<person name="Buxton F.P."/>
<person name="Zhu J."/>
<person name="Song C."/>
<person name="Labow M.A."/>
</authorList>
<dbReference type="PubMed" id="14506290"/>
<dbReference type="DOI" id="10.1073/pnas.1932773100"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>VARIANT CYS-379</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="2">
<citation type="submission" date="2005-04" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Totoki Y."/>
<person name="Toyoda A."/>
<person name="Takeda T."/>
<person name="Sakaki Y."/>
<person name="Tanaka A."/>
<person name="Yokoyama S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="2006" name="Nature" volume="441" first="315" last="321">
<title>The DNA sequence and biological annotation of human chromosome 1.</title>
<authorList>
<person name="Gregory S.G."/>
<person name="Barlow K.F."/>
<person name="McLay K.E."/>
<person name="Kaul R."/>
<person name="Swarbreck D."/>
<person name="Dunham A."/>
<person name="Scott C.E."/>
<person name="Howe K.L."/>
<person name="Woodfine K."/>
<person name="Spencer C.C.A."/>
<person name="Jones M.C."/>
<person name="Gillson C."/>
<person name="Searle S."/>
<person name="Zhou Y."/>
<person name="Kokocinski F."/>
<person name="McDonald L."/>
<person name="Evans R."/>
<person name="Phillips K."/>
<person name="Atkinson A."/>
<person name="Cooper R."/>
<person name="Jones C."/>
<person name="Hall R.E."/>
<person name="Andrews T.D."/>
<person name="Lloyd C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Anderson F."/>
<person name="Andrew R.W."/>
<person name="Ashwell R.I.S."/>
<person name="Aubin K."/>
<person name="Babbage A.K."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Beasley H."/>
<person name="Bethel G."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown J.Y."/>
<person name="Brown A.J."/>
<person name="Buckley D."/>
<person name="Burton J."/>
<person name="Bye J."/>
<person name="Carder C."/>
<person name="Chapman J.C."/>
<person name="Clark S.Y."/>
<person name="Clarke G."/>
<person name="Clee C."/>
<person name="Cobley V."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Coville G.J."/>
<person name="Davies J."/>
<person name="Deadman R."/>
<person name="Dunn M."/>
<person name="Earthrowl M."/>
<person name="Ellington A.G."/>
<person name="Errington H."/>
<person name="Frankish A."/>
<person name="Frankland J."/>
<person name="French L."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Gay L."/>
<person name="Ghori M.R.J."/>
<person name="Gibson R."/>
<person name="Gilby L.M."/>
<person name="Gillett W."/>
<person name="Glithero R.J."/>
<person name="Grafham D.V."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Hammond S."/>
<person name="Harrison E.S.I."/>
<person name="Hart E."/>
<person name="Haugen E."/>
<person name="Heath P.D."/>
<person name="Holmes S."/>
<person name="Holt K."/>
<person name="Howden P.J."/>
<person name="Hunt A.R."/>
<person name="Hunt S.E."/>
<person name="Hunter G."/>
<person name="Isherwood J."/>
<person name="James R."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A."/>
<person name="Kay M."/>
<person name="Kershaw J.K."/>
<person name="Kibukawa M."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A.J."/>
<person name="Lad H."/>
<person name="Laird G."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Lloyd D.M."/>
<person name="Loveland J."/>
<person name="Lovell J."/>
<person name="Lush M.J."/>
<person name="Lyne R."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="Matthews N.S.W."/>
<person name="McLaren S."/>
<person name="Milne S."/>
<person name="Mistry S."/>
<person name="Moore M.J.F."/>
<person name="Nickerson T."/>
<person name="O'Dell C.N."/>
<person name="Oliver K."/>
<person name="Palmeiri A."/>
<person name="Palmer S.A."/>
<person name="Parker A."/>
<person name="Patel D."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Pelan S."/>
<person name="Phelps K."/>
<person name="Phillimore B.J."/>
<person name="Plumb R."/>
<person name="Rajan J."/>
<person name="Raymond C."/>
<person name="Rouse G."/>
<person name="Saenphimmachak C."/>
<person name="Sehra H.K."/>
<person name="Sheridan E."/>
<person name="Shownkeen R."/>
<person name="Sims S."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C."/>
<person name="Subramanian S."/>
<person name="Sycamore N."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Van Helmond Z."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="White S."/>
<person name="Whitehead S.L."/>
<person name="Wilkinson J.E."/>
<person name="Willey D.L."/>
<person name="Williams H."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Wu Z."/>
<person name="Coulson A."/>
<person name="Vaudin M."/>
<person name="Sulston J.E."/>
<person name="Durbin R.M."/>
<person name="Hubbard T."/>
<person name="Wooster R."/>
<person name="Dunham I."/>
<person name="Carter N.P."/>
<person name="McVean G."/>
<person name="Ross M.T."/>
<person name="Harrow J."/>
<person name="Olson M.V."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Bentley D.R."/>
</authorList>
<dbReference type="PubMed" id="16710414"/>
<dbReference type="DOI" id="10.1038/nature04727"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>PNS</tissue>
<tissue>Urinary bladder</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2003" name="Mol. Cell" volume="12" first="413" last="423">
<title>TORCs: transducers of regulated CREB activity.</title>
<authorList>
<person name="Conkright M.D."/>
<person name="Canettieri G."/>
<person name="Screaton R."/>
<person name="Guzman E."/>
<person name="Miraglia L."/>
<person name="Hogenesch J.B."/>
<person name="Montminy M."/>
</authorList>
<dbReference type="PubMed" id="14536081"/>
<dbReference type="DOI" id="10.1016/j.molcel.2003.08.013"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Cell" volume="119" first="61" last="74">
<title>The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector.</title>
<authorList>
<person name="Screaton R.A."/>
<person name="Conkright M.D."/>
<person name="Katoh Y."/>
<person name="Best J.L."/>
<person name="Canettieri G."/>
<person name="Jeffries S."/>
<person name="Guzman E."/>
<person name="Niessen S."/>
<person name="Yates J.R. III"/>
<person name="Takemori H."/>
<person name="Okamoto M."/>
<person name="Montminy M."/>
</authorList>
<dbReference type="PubMed" id="15454081"/>
<dbReference type="DOI" id="10.1016/j.cell.2004.09.015"/>
</citation>
<scope>INTERACTION WITH CREB1; SIK2; PPP3CA; YWHAB AND YWHAG</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT SER-70; SER-90; SER-136; SER-171; SER-306; SER-368; SER-393; SER-433; SER-456; SER-489; SER-492 AND SER-613</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>MUTAGENESIS OF SER-171 AND SER-368</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Curr. Biol." volume="14" first="2156" last="2161">
<title>Activation of cAMP response element-mediated gene expression by regulated nuclear transport of TORC proteins.</title>
<authorList>
<person name="Bittinger M.A."/>
<person name="McWhinnie E."/>
<person name="Meltzer J."/>
<person name="Iourgenko V."/>
<person name="Latario B."/>
<person name="Liu X."/>
<person name="Chen C.H."/>
<person name="Song C."/>
<person name="Garza D."/>
<person name="Labow M."/>
</authorList>
<dbReference type="PubMed" id="15589160"/>
<dbReference type="DOI" id="10.1016/j.cub.2004.11.002"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2006" name="FEBS J." volume="273" first="2730" last="2748">
<title>Silencing the constitutive active transcription factor CREB by the LKB1-SIK signaling cascade.</title>
<authorList>
<person name="Katoh Y."/>
<person name="Takemori H."/>
<person name="Lin X.-Z."/>
<person name="Tamura M."/>
<person name="Muraoka M."/>
<person name="Satoh T."/>
<person name="Tsuchiya Y."/>
<person name="Min L."/>
<person name="Doi J."/>
<person name="Miyauchi A."/>
<person name="Witters L.A."/>
<person name="Nakamura H."/>
<person name="Okamoto M."/>
</authorList>
<dbReference type="PubMed" id="16817901"/>
<dbReference type="DOI" id="10.1111/j.1742-4658.2006.05291.x"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>PHOSPHORYLATION AT SER-171</scope>
<scope>MUTAGENESIS OF SER-171</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2006" name="J. Virol." volume="80" first="7052" last="7059">
<title>TORC1 and TORC2 coactivators are required for tax activation of the human T-cell leukemia virus type 1 long terminal repeats.</title>
<authorList>
<person name="Siu Y.-T."/>
<person name="Chin K.-T."/>
<person name="Siu K.-L."/>
<person name="Yee Wai Choy E."/>
<person name="Jeang K.-T."/>
<person name="Jin D.-Y."/>
</authorList>
<dbReference type="PubMed" id="16809310"/>
<dbReference type="DOI" id="10.1128/jvi.00103-06"/>
</citation>
<scope>INTERACTION WITH HTLV-1 TAX (MICROBIAL INFECTION)</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-433</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="14379" last="14384">
<title>Transducer of regulated CREB-binding proteins (TORCs) induce PGC-1alpha transcription and mitochondrial biogenesis in muscle cells.</title>
<authorList>
<person name="Wu Z."/>
<person name="Huang X."/>
<person name="Feng Y."/>
<person name="Handschin C."/>
<person name="Feng Y."/>
<person name="Gullicksen P.S."/>
<person name="Bare O."/>
<person name="Labow M."/>
<person name="Spiegelman B."/>
<person name="Stevenson S.C."/>
</authorList>
<dbReference type="PubMed" id="16980408"/>
<dbReference type="DOI" id="10.1073/pnas.0606714103"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2007" name="Mol. Cell. Endocrinol." volume="265" first="196" last="204">
<title>Dephosphorylation of TORC initiates expression of the StAR gene.</title>
<authorList>
<person name="Takemori H."/>
<person name="Kanematsu M."/>
<person name="Kajimura J."/>
<person name="Hatano O."/>
<person name="Katoh Y."/>
<person name="Lin X.-Z."/>
<person name="Min L."/>
<person name="Yamazaki T."/>
<person name="Doi J."/>
<person name="Okamoto M."/>
</authorList>
<dbReference type="PubMed" id="17210223"/>
<dbReference type="DOI" id="10.1016/j.mce.2006.12.020"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT SER-171</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-433</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10161" last="10166">
<title>Glucose controls CREB activity in islet cells via regulated phosphorylation of TORC2.</title>
<authorList>
<person name="Jansson D."/>
<person name="Ng A.C."/>
<person name="Fu A."/>
<person name="Depatie C."/>
<person name="Al Azzabi M."/>
<person name="Screaton R.A."/>
</authorList>
<dbReference type="PubMed" id="18626018"/>
<dbReference type="DOI" id="10.1073/pnas.0800796105"/>
</citation>
<scope>PHOSPHORYLATION AT SER-171 AND SER-274</scope>
<scope>INTERACTION WITH 14-3-3</scope>
<scope>MUTAGENESIS OF SER-171; SER-274 AND SER-368</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70; SER-86; SER-90; SER-136; SER-433; THR-501; SER-613 AND SER-624</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-70; SER-86; SER-90; THR-192; SER-433; TYR-488; SER-490; SER-613 AND SER-624</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-501; SER-613 AND SER-624</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-433; SER-613 AND SER-624</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-90 AND SER-613</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="24">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-234</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2018" name="IScience" volume="11" first="134" last="145">
<title>Mitogenic Signals Stimulate the CREB Coactivator CRTC3 through PP2A Recruitment.</title>
<authorList>
<person name="Sonntag T."/>
<person name="Ostojic J."/>
<person name="Vaughan J.M."/>
<person name="Moresco J.J."/>
<person name="Yoon Y.S."/>
<person name="Yates J.R. III"/>
<person name="Montminy M."/>
</authorList>
<dbReference type="PubMed" id="30611118"/>
<dbReference type="DOI" id="10.1016/j.isci.2018.12.012"/>
</citation>
<scope>INTERACTION WITH YWHAE AND PPP3CA</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2008" name="Mol. Genet. Metab." volume="93" first="200" last="209">
<title>Single nucleotide polymorphisms in genes encoding LKB1 (STK11), TORC2 (CRTC2) and AMPK alpha2-subunit (PRKAA2) and risk of type 2 diabetes.</title>
<authorList>
<person name="Keshavarz P."/>
<person name="Inoue H."/>
<person name="Nakamura N."/>
<person name="Yoshikawa T."/>
<person name="Tanahashi T."/>
<person name="Itakura M."/>
</authorList>
<dbReference type="PubMed" id="17950019"/>
<dbReference type="DOI" id="10.1016/j.ymgme.2007.08.125"/>
</citation>
<scope>VARIANT CYS-379</scope>
<scope>INVOLVEMENT IN SUSCEPTIBILITY TO NIDDM</scope>
</reference>
<comment type="function">
<text evidence="14 15 16 18 19 20 21">Transcriptional coactivator for CREB1 which activates transcription through both consensus and variant cAMP response element (CRE) sites. Acts as a coactivator, in the SIK/TORC signaling pathway, being active when dephosphorylated and acts independently of CREB1 'Ser-133' phosphorylation. Enhances the interaction of CREB1 with TAF4. Regulates gluconeogenesis as a component of the LKB1/AMPK/TORC2 signaling pathway. Regulates the expression of specific genes such as the steroidogenic gene, StAR. Potent coactivator of PPARGC1A and inducer of mitochondrial biogenesis in muscle cells. Also coactivator for TAX activation of the human T-cell leukemia virus type 1 (HTLV-1) long terminal repeats (LTR).</text>
</comment>
<comment type="subunit">
<text evidence="13 16 23 24">Binds, as a tetramer, through its N-terminal region, with the bZIP domain of CREB1 (PubMed:15454081). 'Arg-314' in the bZIP domain of CREB1 is essential for this interaction (PubMed:15454081). Interaction, via its C-terminal, with TAF4, enhances recruitment of TAF4 to CREB1 (PubMed:15454081). Interacts with SIK2 (PubMed:15454081). Interacts with 14-3-3 proteins, YWHAB and YWHAG (PubMed:15454081, PubMed:18626018). Interacts (probably when phosphorylated at Ser-171) with YWHAE (PubMed:30611118). Interacts with calmodulin-dependent catalytic subunit PPP3CA/calcineurin A (PubMed:15454081, PubMed:30611118). Interaction with COP1 mediates nuclear export and degradation of CRTC2 (By similarity).</text>
</comment>
<comment type="subunit">
<text evidence="18">(Microbial infection) Interaction with the human T-cell leukemia virus type 1 (HTLV-1) Tax protein is essential for optimal transcription activation by Tax.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1181987">
<id>Q53ET0</id>
</interactant>
<interactant intactId="EBI-852157">
<id>P18850</id>
<label>ATF6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1181987">
<id>Q53ET0</id>
</interactant>
<interactant intactId="EBI-1166928">
<id>Q8N5M1</id>
<label>ATPAF2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1181987">
<id>Q53ET0</id>
</interactant>
<interactant intactId="EBI-10961624">
<id>Q2TAC2-2</id>
<label>CCDC57</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1181987">
<id>Q53ET0</id>
</interactant>
<interactant intactId="EBI-396137">
<id>Q9UJX2</id>
<label>CDC23</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1181987">
<id>Q53ET0</id>
</interactant>
<interactant intactId="EBI-711855">
<id>P16220</id>
<label>CREB1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1181987">
<id>Q53ET0</id>
</interactant>
<interactant intactId="EBI-350527">
<id>Q15233</id>
<label>NONO</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1181987">
<id>Q53ET0</id>
</interactant>
<interactant intactId="EBI-740595">
<id>Q9UMX1</id>
<label>SUFU</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1181987">
<id>Q53ET0</id>
</interactant>
<interactant intactId="EBI-2621186">
<id>P03206</id>
<label>BZLF1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="17">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="17">Nucleus</location>
</subcellularLocation>
<text evidence="16">Translocated from the nucleus to the cytoplasm on interaction of the phosphorylated form with 14-3-3 protein (PubMed:15454081). In response to cAMP levels and glucagon, relocated to the nucleus (PubMed:15454081).</text>
</comment>
<comment type="tissue specificity">
<text evidence="15 16 20">Most abundantly expressed in the thymus. Present in both B and T-lymphocytes. Highly expressed in HEK293T cells and in insulinomas. High levels also in spleen, ovary, muscle and lung, with highest levels in muscle. Lower levels found in brain, colon, heart, kidney, prostate, small intestine and stomach. Weak expression in liver and pancreas.</text>
</comment>
<comment type="PTM">
<text evidence="13 16 17 19 21 23">Phosphorylation/dephosphorylation states of Ser-171 are required for regulating transduction of CREB activity (PubMed:15589160, PubMed:17210223). CRTCs/TORCs are inactive when phosphorylated, and active when dephosphorylated at this site (PubMed:17210223). This primary site of phosphorylation, is regulated by cAMP and calcium levels and is dependent on the phosphorylation of SIKs (SIK1 and SIK2) by LKB1 (PubMed:15454081, PubMed:16817901). Following adenylyl cyclase activation, dephosphorylated at Ser-171 by PPP3CA/calcineurin A resulting in CRTC2 dissociation from 14-3-3 proteins and PPP3CA (By similarity). Both insulin and AMPK increase this phosphorylation of CRTC2 while glucagon suppresses it (PubMed:15454081). Phosphorylation at Ser-274 by MARK2 is induced under low glucose conditions and dephosphorylated in response to glucose influx (PubMed:18626018). Phosphorylation at Ser-274 promotes interaction with 14-3-3 proteins and translocation to the cytoplasm (PubMed:18626018).</text>
</comment>
<comment type="PTM">
<text evidence="13">Asymmetric dimethylation of arginine resisues by PRMT6 enhances the association of CRTC2 with CREB on the promoters of gluconeogenic genes.</text>
</comment>
<comment type="polymorphism">
<text evidence="22">Variant Cys-379, under a dominant model, linked to a recessive mutation in LKB1, may be associated with susceptibility to type II or non-insulin-dependent diabetes mellitus (NIDDM).</text>
</comment>
<comment type="similarity">
<text evidence="25">Belongs to the TORC family.</text>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/CRTC2ID50581ch1q21.html"/>
</comment>
<dbReference type="EMBL" id="AY360172">
<property type="protein sequence ID" value="AAQ98857.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK223559">
<property type="protein sequence ID" value="BAD97279.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL358472">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC028886">
<property type="protein sequence ID" value="AAH28886.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC053562">
<property type="protein sequence ID" value="AAH53562.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS30875.1"/>
<dbReference type="RefSeq" id="NP_859066.1">
<property type="nucleotide sequence ID" value="NM_181715.2"/>
</dbReference>
<dbReference type="PDB" id="4HTM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A=18-50"/>
</dbReference>
<dbReference type="PDBsum" id="4HTM"/>
<dbReference type="SMR" id="Q53ET0"/>
<dbReference type="BioGRID" id="128308">
<property type="interactions" value="46"/>
</dbReference>
<dbReference type="DIP" id="DIP-29950N"/>
<dbReference type="IntAct" id="Q53ET0">
<property type="interactions" value="28"/>
</dbReference>
<dbReference type="MINT" id="Q53ET0"/>
<dbReference type="STRING" id="9606.ENSP00000357622"/>
<dbReference type="GlyGen" id="Q53ET0">
<property type="glycosylation" value="1 site, 1 O-linked glycan (1 site)"/>
</dbReference>
<dbReference type="iPTMnet" id="Q53ET0"/>
<dbReference type="PhosphoSitePlus" id="Q53ET0"/>
<dbReference type="BioMuta" id="CRTC2"/>
<dbReference type="DMDM" id="167009135"/>
<dbReference type="EPD" id="Q53ET0"/>
<dbReference type="jPOST" id="Q53ET0"/>
<dbReference type="MassIVE" id="Q53ET0"/>
<dbReference type="MaxQB" id="Q53ET0"/>
<dbReference type="PaxDb" id="Q53ET0"/>
<dbReference type="PeptideAtlas" id="Q53ET0"/>
<dbReference type="PRIDE" id="Q53ET0"/>
<dbReference type="ProteomicsDB" id="62448"/>
<dbReference type="Antibodypedia" id="34141">
<property type="antibodies" value="534 antibodies"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000368633">
<property type="protein sequence ID" value="ENSP00000357622"/>
<property type="gene ID" value="ENSG00000160741"/>
</dbReference>
<dbReference type="GeneID" id="200186"/>
<dbReference type="KEGG" id="hsa:200186"/>
<dbReference type="UCSC" id="uc057leo.1">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="200186"/>
<dbReference type="DisGeNET" id="200186"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000160741.16"/>
<dbReference type="GeneCards" id="CRTC2"/>
<dbReference type="HGNC" id="HGNC:27301">
<property type="gene designation" value="CRTC2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000160741">
<property type="expression patterns" value="Low tissue specificity"/>
</dbReference>
<dbReference type="MIM" id="608972">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q53ET0"/>
<dbReference type="OpenTargets" id="ENSG00000160741"/>
<dbReference type="PharmGKB" id="PA142672073"/>
<dbReference type="eggNOG" id="ENOG502QVWA">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00390000010652"/>
<dbReference type="InParanoid" id="Q53ET0"/>
<dbReference type="KO" id="K16333"/>
<dbReference type="OMA" id="RHIIDSS"/>
<dbReference type="OrthoDB" id="1118500at2759"/>
<dbReference type="PhylomeDB" id="Q53ET0"/>
<dbReference type="TreeFam" id="TF321571"/>
<dbReference type="PathwayCommons" id="Q53ET0"/>
<dbReference type="Reactome" id="R-HSA-2151201">
<property type="pathway name" value="Transcriptional activation of mitochondrial biogenesis"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-400253">
<property type="pathway name" value="Circadian Clock"/>
</dbReference>
<dbReference type="SIGNOR" id="Q53ET0"/>
<dbReference type="BioGRID-ORCS" id="200186">
<property type="hits" value="23 hits in 875 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="CRTC2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="CRTC2"/>
<dbReference type="GenomeRNAi" id="200186"/>
<dbReference type="Pharos" id="Q53ET0">
<property type="development level" value="Tbio"/>
</dbReference>
<dbReference type="PRO" id="PR:Q53ET0"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 1"/>
</dbReference>
<dbReference type="RNAct" id="Q53ET0">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000160741">
<property type="expression patterns" value="Expressed in small intestine Peyer's patch and 185 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q53ET0">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q53ET0">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070062">
<property type="term" value="C:extracellular exosome"/>
<property type="evidence" value="ECO:0007005"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008140">
<property type="term" value="F:cAMP response element binding protein binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006094">
<property type="term" value="P:gluconeogenesis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042593">
<property type="term" value="P:glucose homeostasis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043970">
<property type="term" value="P:histone H3-K9 acetylation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0032793">
<property type="term" value="P:positive regulation of CREB transcription factor activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0051289">
<property type="term" value="P:protein homotetramerization"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:1901998">
<property type="term" value="P:toxin transport"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016032">
<property type="term" value="P:viral process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="InterPro" id="IPR024786">
<property type="entry name" value="TORC"/>
</dbReference>
<dbReference type="InterPro" id="IPR024785">
<property type="entry name" value="TORC_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR024784">
<property type="entry name" value="TORC_M"/>
</dbReference>
<dbReference type="InterPro" id="IPR024783">
<property type="entry name" value="TORC_N"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR13589">
<property type="entry name" value="PTHR13589"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF12886">
<property type="entry name" value="TORC_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF12885">
<property type="entry name" value="TORC_M"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF12884">
<property type="entry name" value="TORC_N"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0010">Activator</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="5 8">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="CREB-regulated transcription coactivator 2" id="PRO_0000318528">
<location>
<begin position="2"/>
<end position="693"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear export signal" evidence="12">
<location>
<begin position="271"/>
<end position="287"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Ser">
<location>
<begin position="236"/>
<end position="240"/>
</location>
</feature>
<feature type="compositionally biased region" description="Ser-rich">
<location>
<begin position="336"/>
<end position="408"/>
</location>
</feature>
<feature type="site" description="Required for ubiquitination and degradation" evidence="12">
<location>
<position position="629"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="5 8">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; by PRMT6" evidence="13">
<location>
<position position="51"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 6 16">
<location>
<position position="70"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 6">
<location>
<position position="86"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 6 10 16">
<location>
<position position="90"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; by PRMT6" evidence="13">
<location>
<position position="99"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; by PRMT6" evidence="13">
<location>
<position position="120"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; by PRMT6" evidence="13">
<location>
<position position="123"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 16">
<location>
<position position="136"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; by PRMT6" evidence="13">
<location>
<position position="161"/>
</location>
</feature>
<feature type="modified residue" description="Asymmetric dimethylarginine; by PRMT6" evidence="13">
<location>
<position position="168"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="13">
<location>
<position position="169"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by AMPK, MARK2, SIK1 and SIK2" evidence="16 19 21 23">
<location>
<position position="171"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="6">
<location>
<position position="192"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by MARK2" evidence="23">
<location>
<position position="274"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="16">
<location>
<position position="306"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="16">
<location>
<position position="368"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="16">
<location>
<position position="393"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 3 4 6 9 16">
<location>
<position position="433"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="16">
<location>
<position position="456"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine" evidence="6">
<location>
<position position="488"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="16">
<location>
<position position="489"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="6">
<location>
<position position="490"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="16">
<location>
<position position="492"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="4 7">
<location>
<position position="501"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 6 7 9 10 16">
<location>
<position position="613"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13">
<location>
<position position="623"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="4 6 7 9">
<location>
<position position="624"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="11">
<location>
<position position="234"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs11264680." id="VAR_038756">
<original>M</original>
<variation>V</variation>
<location>
<position position="147"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs150423770." id="VAR_038757" evidence="14 22">
<original>R</original>
<variation>C</variation>
<location>
<position position="379"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on cAMP- and calcium-regulated phosphorylation.">
<original>S</original>
<variation>A</variation>
<location>
<position position="70"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of cAMP- and calcium-regulated phosphorylation. Greatly reduced interaction with 14-3-3 proteins. Impaired phosphorylation under low glucose conditions and impaired interaction with 14-3-3 proteins; when associated with A-274." evidence="16 19 23">
<original>S</original>
<variation>A</variation>
<location>
<position position="171"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired phosphorylation under low glucose conditions and impaired interaction with 14-3-3 proteins; when associated with A-171." evidence="23">
<original>S</original>
<variation>A</variation>
<location>
<position position="274"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduced cAMP- and calcium-regulated phosphorylation." evidence="16 23">
<original>S</original>
<variation>A</variation>
<location>
<position position="368"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on cAMP- and calcium-regulated phosphorylation.">
<original>S</original>
<variation>A</variation>
<location>
<position position="393"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAQ98857." ref="1" evidence="25">
<original>MGL</original>
<variation>HGP</variation>
<location>
<begin position="323"/>
<end position="325"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; BAD97279." ref="2" evidence="25">
<original>P</original>
<variation>S</variation>
<location>
<position position="499"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="21"/>
<end position="45"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4HTM"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18220336"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000250"/>
<evidence key="13" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q3U182"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14506290"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14536081"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15454081"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15589160"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16809310"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16817901"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16980408"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17210223"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17950019"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18626018"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30611118"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000305"/>
<sequence length="693" mass="73302" checksum="EE6C52E0ECDC1DF1" modified="2008-02-05" version="2">MATSGANGPGSATASASNPRKFSEKIALQKQRQAEETAAFEEVMMDIGSTRLQAQKLRLAYTRSSHYGGSLPNVNQIGSGLAEFQSPLHSPLDSSRSTRHHGLVERVQRDPRRMVSPLRRYTRHIDSSPYSPAYLSPPPESSWRRTMAWGNFPAEKGQLFRLPSALNRTSSDSALHTSVMNPSPQDTYPGPTPPSILPSRRGGILDGEMDPKVPAIEENLLDDKHLLKPWDAKKLSSSSSRPRSCEVPGINIFPSPDQPANVPVLPPAMNTGGSLPDLTNLHFPPPLPTPLDPEETAYPSLSGGNSTSNLTHTMTHLGISRGMGLGPGYDAPGLHSPLSHPSLQSSLSNPNLQASLSSPQPQLQGSHSHPSLPASSLARHVLPTTSLGHPSLSAPALSSSSSSSSTSSPVLGAPSYPASTPGASPHHRRVPLSPLSLLAGPADARRSQQQLPKQFSPTMSPTLSSITQGVPLDTSKLSTDQRLPPYPYSSPSLVLPTQPHTPKSLQQPGLPSQSCSVQSSGGQPPGRQSHYGTPYPPGPSGHGQQSYHRPMSDFNLGNLEQFSMESPSASLVLDPPGFSEGPGFLGGEGPMGGPQDPHTFNHQNLTHCSRHGSGPNIILTGDSSPGFSKEIAAALAGVPGFEVSAAGLELGLGLEDELRMEPLGLEGLNMLSDPCALLPDPAVEESFRSDRLQ</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

